Antonio Morales-Piga

Summary

Affiliation: Instituto de Salud Carlos III
Country: Spain

Publications

  1. doi request reprint Osteochondral diseases and fibrodysplasia ossificans progressiva
    Antonio Morales-Piga
    Jefe de Servicio de Proyectos Clínicos del Instituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III, Sinesio Delgado, 6, 28029, Madrid, Spain
    Adv Exp Med Biol 686:335-48. 2010
  2. doi request reprint Osteochondromas in fibrodysplasia ossificans progressiva: a widespread trait with a streaking but overlooked appearance when arising at femoral bone end
    A Morales-Piga
    Rare Disease Research Institute Instituto de Investigación de Enfermedades Raras IIER, Carlos III Institute of Health Instituto de Salud Carlos III ISCIII, Monforte de Lemos, 5, 28029, Madrid, Spain
    Rheumatol Int 35:1759-67. 2015
  3. doi request reprint Is "fibrodysplasia ossificans progressiva" a vascular disease? A groundbreaking pathogenic model
    Antonio Morales-Piga
    Instituto de Investigacion de Enfermedades Raras, Centro de Investigación Biomédica en Red de Enfermedades Raras CIBERER, Instituto de Salud Carlos III, Madrid, España Electronic address
    Reumatol Clin 10:389-95. 2014
  4. doi request reprint [Is there a place in primary care for rare diseases? The case of fibrodysplasia ossificans progressiva]
    Antonio Morales-Piga
    Instituto de Investigación de Enfermedades Raras IIER, Instituto de Salud Carlos III, Madrid, Spain
    Aten Primaria 45:324-8. 2013
  5. ncbi request reprint Further evidence supporting a genetic background for Paget's disease of bone in Spain
    A Morales-Piga
    Rare Disease Research Institute, Carlos III Institute of Health, Madrid, Spain
    Anthropol Anz 69:417-22. 2012
  6. doi request reprint Fibrodysplasia ossificans progressiva in Spain: epidemiological, clinical, and genetic aspects
    A Morales-Piga
    Rare Disease Research Institute Instituto de Investigación de Enfermedades Raras IIER, Carlos III Institute of Health Instituto de Salud Carlos III ISCIII, Madrid, Spain
    Bone 51:748-55. 2012
  7. doi request reprint [Implications of the new etiophatogenic approach in the classification of constitutional and genetic bone diseases]
    Antonio Morales Piga
    Instituto de Investigacion de Enfermedades Raras, Centro de Investigación Biomédica en Red de Enfermedades Raras CIBERER, Instituto de Salud Carlos III, Madrid, Espana
    Reumatol Clin 7:248-54. 2011
  8. doi request reprint Increase in motor neuron disease mortality in Spain: temporal and geographical analysis (1990-2005)
    Veronica Alonso
    Rare Diseases Research Institute, Instituto de Salud Carlos III, Madrid, Spain
    Amyotroph Lateral Scler 12:192-8. 2011
  9. doi request reprint Epidemiology of hereditary ataxias in Spain: hospital discharge registry and population-based mortality study
    Veronica Alonso
    Rare Diseases Research Institute, Instituto de Salud Carlos III, Madrid, Spain
    Neuroepidemiology 41:13-9. 2013
  10. doi request reprint Mortality of congenital osteochondrodysplasias: a nationwide registry-based study
    Antonio Morales-Piga
    Rare Disease Research Institute Instituto de Investigación de Enfermedades Raras IIER, Carlos III Institute of Health Instituto de Salud Carlos III ISCIII, Madrid, Spain
    Am J Med Genet A 161:1555-60. 2013

Collaborators

Detail Information

Publications11

  1. doi request reprint Osteochondral diseases and fibrodysplasia ossificans progressiva
    Antonio Morales-Piga
    Jefe de Servicio de Proyectos Clínicos del Instituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III, Sinesio Delgado, 6, 28029, Madrid, Spain
    Adv Exp Med Biol 686:335-48. 2010
    ..Large regional centres will improve diagnosis performance, provide accurate genetic counselling, and ensure an integral assistance for these often severe and incapacitating conditions...
  2. doi request reprint Osteochondromas in fibrodysplasia ossificans progressiva: a widespread trait with a streaking but overlooked appearance when arising at femoral bone end
    A Morales-Piga
    Rare Disease Research Institute Instituto de Investigación de Enfermedades Raras IIER, Carlos III Institute of Health Instituto de Salud Carlos III ISCIII, Monforte de Lemos, 5, 28029, Madrid, Spain
    Rheumatol Int 35:1759-67. 2015
    ..Unveiling the molecular links between these physiopathological pathways could help to illuminate the mechanisms that govern bone morphogenesis. ..
  3. doi request reprint Is "fibrodysplasia ossificans progressiva" a vascular disease? A groundbreaking pathogenic model
    Antonio Morales-Piga
    Instituto de Investigacion de Enfermedades Raras, Centro de Investigación Biomédica en Red de Enfermedades Raras CIBERER, Instituto de Salud Carlos III, Madrid, España Electronic address
    Reumatol Clin 10:389-95. 2014
    ..In this article we summarize these breakthroughs, with implications that go beyond the limits of this devastating disease to insinuate a new model of human pathophysiology. ..
  4. doi request reprint [Is there a place in primary care for rare diseases? The case of fibrodysplasia ossificans progressiva]
    Antonio Morales-Piga
    Instituto de Investigación de Enfermedades Raras IIER, Instituto de Salud Carlos III, Madrid, Spain
    Aten Primaria 45:324-8. 2013
    ..The quality of care in rare diseases must not be inferior to that provided to the other chronic diseases, since, besides being a requirement of justice and fairness, these patients are, in essence, the "paradigm of chronicity"...
  5. ncbi request reprint Further evidence supporting a genetic background for Paget's disease of bone in Spain
    A Morales-Piga
    Rare Disease Research Institute, Carlos III Institute of Health, Madrid, Spain
    Anthropol Anz 69:417-22. 2012
    ..75-347.00) in the multivariate analysis. In conclusion, heritable factors are crucial in the pathogenesis of PD and, in line with other data sources, might account for the ethnic predisposition observed in different countries...
  6. doi request reprint Fibrodysplasia ossificans progressiva in Spain: epidemiological, clinical, and genetic aspects
    A Morales-Piga
    Rare Disease Research Institute Instituto de Investigación de Enfermedades Raras IIER, Carlos III Institute of Health Instituto de Salud Carlos III ISCIII, Madrid, Spain
    Bone 51:748-55. 2012
    ..The molecular characterization of ACVR1 sequence variation will contribute to the understanding of the genetic profile of this devastating disease in different geographical areas...
  7. doi request reprint [Implications of the new etiophatogenic approach in the classification of constitutional and genetic bone diseases]
    Antonio Morales Piga
    Instituto de Investigacion de Enfermedades Raras, Centro de Investigación Biomédica en Red de Enfermedades Raras CIBERER, Instituto de Salud Carlos III, Madrid, Espana
    Reumatol Clin 7:248-54. 2011
    ..Elucidation of the damaged underlying molecular mechanisms offers targets potentially useful for therapeutic research in these complex and often disabling diseases...
  8. doi request reprint Increase in motor neuron disease mortality in Spain: temporal and geographical analysis (1990-2005)
    Veronica Alonso
    Rare Diseases Research Institute, Instituto de Salud Carlos III, Madrid, Spain
    Amyotroph Lateral Scler 12:192-8. 2011
    ..All these factors may play a very important role in analysis of MND mortality in Spain, and the contribution of each of these will have to be examined in depth by ad hoc studies...
  9. doi request reprint Epidemiology of hereditary ataxias in Spain: hospital discharge registry and population-based mortality study
    Veronica Alonso
    Rare Diseases Research Institute, Instituto de Salud Carlos III, Madrid, Spain
    Neuroepidemiology 41:13-9. 2013
    ..Hereditary ataxias (HA) comprise a group of genetically heterogeneous rare diseases. As important public health problems to be monitored, this study analyses the morbimortality of HA in Spain...
  10. doi request reprint Mortality of congenital osteochondrodysplasias: a nationwide registry-based study
    Antonio Morales-Piga
    Rare Disease Research Institute Instituto de Investigación de Enfermedades Raras IIER, Carlos III Institute of Health Instituto de Salud Carlos III ISCIII, Madrid, Spain
    Am J Med Genet A 161:1555-60. 2013
    ..There is a need to identify risk factors and to increase overall knowledge about the life expectancy and epidemiology of osteochondrodysplasias...
  11. doi request reprint Childhood leukemia and residential proximity to industrial and urban sites
    Javier Garcia-Perez
    Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain CIBER Epidemiología y Salud Pública CIBERESP, Spain Electronic address
    Environ Res 140:542-53. 2015
    ..While a small fraction of cases of childhood leukemia might be partially attributable to some diseases or ionizing radiation exposure, the role of industrial and urban pollution also needs to be assessed...